Improved Treatments for Children with Sickle Cell Disease
Department of Health and Human Services Office of Minority Health · October 2, 2024
Department of Health and Human Services Office of Minority Health webinar on a $4.25 million OMH demonstration grant to New York City Health + Hospitals that increased hydroxyurea prescribing for children with sickle cell disease and reported associated reductions in emergency-department visits for patients treated by participating clinicians.
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.
No transcript available.
No outline available for this source.
No related articles available for this source.
No highlights available for this source.
No claims available for this source.
No actions available for this source.
No topics available for this source.
No clarifying details available for this source.
No discussions available for this source.
No community relevance data available for this source.
No funding sources available for this source.
No speakers available for this source.
No transcript available for this source.